Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a chat app help liver disease patients cut back on drinking?

NCT ID NCT06587568

NEW Disease control Sponsor: The University of Hong Kong Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Researchers are testing whether personalized counseling delivered through a mobile chat app can help people with chronic liver disease reduce their alcohol use. The trial enrolls adults with liver disease who drink at risky levels, and compares chat-based support plus brief advice against brief advice alone. The main goal is to see whether this approach is practical and acceptable, and to gather early data on drinking and liver health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Personalized alcohol reduction counseling delivered through a mobile instant messaging app, plus brief advice and a self-help booklet
What this could lead to
If the approach proves feasible, it could offer a low-cost, easy-to-reach way to help people with chronic liver disease cut back on drinking, and it could inform a larger trial.
What could go wrong
This is a small pilot study designed mainly to test whether the method works logistically, not to prove that it reduces drinking. The results may not hold in a larger group, and some participants may not engage with the chat format.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

106 people

The number who actually took part.

Started

Oct 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥18 years 2. Diagnosed with chronic liver disease 3. Alcohol Use Disorders Identification Test score ≥8 4. Own a smartphone with a mobile instant messaging app installed 5. Able to read and communicate in Chinese Exclusion Criteria: 1. Having a psychiatric or psychological disease or on psychotropic drugs 2. Participating in other alcohol reduction or abstinence programmes 3. Require emergency or in-patient treatment after consultation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic liver disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fibrosis hepatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic liver disease

Contacts and locations

Locations

  • Queen Mary Hospital

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.